# Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

> **NCT00948324** · PHASE4 · SUSPENDED · sponsor: **Sun Yat-sen University** · enrollment: 400 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** CSII,ALA,MET,RSG

## Key facts

- **NCT ID:** NCT00948324
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2008-06
- **Primary completion:** 2019-05
- **Final completion:** 2021-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00948324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00948324, "Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00948324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*